Page d'accueil  |  Aide  |  Effacer
Anglais  |  Français
 Rechercher  |  Catégories  |  Titres A-Z  |  Pays  |  Comparer pays  |  Index  
Etendre sommaire
Document complet
Dérouler chapitre
Préférences

fermer ce livreStandard Treatment Guidelines (STG) and The National Essential Drug List for Tanzania (NEDLIT) (WHO; 1997; 210 pages)
Afficher le documentFOREWORD
Afficher le documentACKNOWLEDGMENTS
Afficher le documentINTRODUCTION
fermer ce répertoireStandard Treatment Guidelines (STG)
ouvrir ce répertoire et afficher son contenu1. GASTROINTESTINAL CONDITIONS
ouvrir ce répertoire et afficher son contenu2. RESPIRATORY DISEASES
ouvrir ce répertoire et afficher son contenu3. OBSTETRIC AND GYNAECOLOGICAL CONDITIONS AND CONTRACEPTION
ouvrir ce répertoire et afficher son contenu4. CARDIOVASCULAR DISEASES
fermer ce répertoire5. MALARIA
Afficher le document5.1 General Guidelines
Afficher le document5.2 Uncomplicated Malaria, Chloroquine Sensitive
Afficher le document5.3 Uncomplicated Malaria, Chloroquine resistant
Afficher le document5.4 Malaria due to vivax/ovale
fermer ce répertoire5.5 Complicated Malaria
Afficher le document5.5.1 General measure
ouvrir ce répertoire et afficher son contenu6. SKIN DISEASES
ouvrir ce répertoire et afficher son contenu7. SEXUALLY TRANSMITTED INFECTIONS / DISEASES (STD)
ouvrir ce répertoire et afficher son contenu8. DENTAL AND ORAL CONDITIONS
ouvrir ce répertoire et afficher son contenu9. GENITO-URINARY DISEASES: KIDNEY CONDITIONS
ouvrir ce répertoire et afficher son contenu10. EAR, NOSE AND THROAT CONDITIONS
ouvrir ce répertoire et afficher son contenu11. EYE CONDITIONS
ouvrir ce répertoire et afficher son contenu12. TUBERCULOSIS AND LEPROSY
ouvrir ce répertoire et afficher son contenu13. MUSCULOSKELETAL CONDITIONS AND JOINT DISEASES
ouvrir ce répertoire et afficher son contenu14. METABOLIC AND ENDOCRINE SYSTEM CONDITIONS
ouvrir ce répertoire et afficher son contenu15. CENTRAL NERVOUS SYSTEM DISEASE CONDITIONS
ouvrir ce répertoire et afficher son contenu16. OTHER DISEASE CONDITIONS
ouvrir ce répertoire et afficher son contenu17. VIRAL INFECTIONS
ouvrir ce répertoire et afficher son contenu18. ALLERGIC REACTIONS
ouvrir ce répertoire et afficher son contenu19. NUTRITIONAL AND HAEMATOLOGIC CONDITIONS
ouvrir ce répertoire et afficher son contenu20. MALIGNANT DISEASE CONDITIONS
ouvrir ce répertoire et afficher son contenu21. INJURIES AND TRAUMA
Afficher le document22. FOREIGN BODIES
Afficher le document23. PAIN
Afficher le document24. POISONING
Afficher le document25. NORMAL LABORATORY VALUES
ouvrir ce répertoire et afficher son contenuNATIONAL ESSENTIAL DRUG LIST
Afficher le documentABBREVIATIONS AND SYMBOLS
 

5.5 Complicated Malaria

• Cerebral malaria
• Severe haemolytic anaemia
• Renal failure
• Severe haemoglobinuria
• Hyperparasitaemia (25 or greater in non-immune or parasites > 100/field in disc smear)


NOTE It is important that therapy is initiated without delay at a district hospital but use discretion and guidelines in referring; Drug treatments assume all cases chloroquine resistant

 

Quinine (IV infusion) 10 mg/kg salt diluted in dextrose 5% given over 4 hours in a total volume of 5 - 10 ml/kg; followed by 10 mg/kg salt every 8 hours in adults and every 12 hours in children up to 4 doses then until the patient can swallow, then give for

Adult

Quinine (O) 600 mg (salt) every 8 hours to complete 7 days treatment.

Children

10 mg/kg (salt) as for adult

CAUTION

• The initial dose should be halved if patient had received quinine, quinidine or mefloquine during the previous 12-24 hours.

• Maintenance dose should be reduced three fold in patients with impaired renal function

• Pulse and blood pressure should be closely monitored during administration

• Rate of infusion be reduced if dysrhythmia occurs.

• Direct IV injection should NOT be given. Hypoglycaemia may occur after I.V administration of Quinine

• IM injection is less satisfactory but may be used to initiate therapy when facilities for IV infusion are NOT available.

The required dose should be divided equally between two sites (one in each anterior flight), Muscle necrosis and sterile abscesses may appear. If possible avoid IM Quinine injection.

In addition give

Pyrimethamine + Sulfadoxine (3 tablets, adult) as a single dose at the end of Quinine treatment

vers la section précédentevers la section suivante

S'il vous plaît envoyez vos commentaires
Abréviations
Anglais  |  Français